Get started
Author

Jimena Pérez

Observed names: J. Perez, JIMENA PEREZ, Jimena Perez, Jimena Pérez, Perez J
OpenAlex ID: A5113766964
SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells
2017 · Hiroyuki Ozawa, Ruchira S. Ranaweera, et al. · Clinical Cancer Research · 72
Differential promoter methylation of kinesin family member 1a in plasma is associated with breast cancer and DNA repair capacity
2014 · RAFAEL GUERRERO-PRESTON, TAL HADAR, et al. · Oncology Reports · 52
PDF
Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma
2015 · Haixia Cheng, Elana J Fertig, et al. · Cancer Biology & Therapy · 45
PDF
Early detection of gastric cancer using global, genome-wide and IRF4, ELMO1, CLIP4 and MSC DNA methylation in endoscopic biopsies
2017 · Francesca Pirini, Sassan Noazin, et al. · Oncotarget · 44
PDF
A 3′-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
2014 · C.H. Chung, J.W. Lee, et al. · Annals of Oncology · 41
PDF
Genome-wide methylation profiling reveals Zinc finger protein 516 (ZNF516) and FK-506-binding protein 6 (FKBP6) promoters frequently methylated in cervical neoplasia, associated with HPV status and ethnicity in a Chilean population
2013 · Priscilla Brebi, Leonel Maldonado, et al. · Epigenetics · 36
PDF
CoGAPS matrix factorization algorithm identifies transcriptional changes in AP-2alpha target genes in feedback from therapeutic inhibition of the EGFR network
2016 · Elana J. Fertig, Hiroyuki Ozawa, et al. · Oncotarget · 17
PDF
Genome-Wide and Gene-Specific Epigenomic Platforms for Hepatocellular Carcinoma Biomarker Development Trials
2014 · Christina Michailidi, Ethan Soudry, et al. · Gastroenterology Research and Practice · 14
PDF
Clinical and public health research using methylated DNA Immunoprecipitation (MeDIP): A comparison of commercially available kits to examine differential DNA methylation across the genome
2012 · Priscilla Brebi-Mieville, Carmen Ili-Gangas, et al. · Epigenetics · 12
PDF
miRNA array analysis determines miR-205 is overexpressed in head and neck squamous cell carcinoma and enhances cellular proliferation
2013 · Howard JD, Cheng H, et al. · Journal of Cancer Research & Therapy · 6
PDF
Cetuximab with or without sorafenib in recurrent/metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN).
2013 · Jill Gilbert, Michael J. Schell, et al. · Journal of Clinical Oncology · 4
Association of the 3'-untranslated region KRAS-variant with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
2013 · Joanne B. Weidhaas, Ju-Whei Lee, et al. · Journal of Clinical Oncology · 3
Abstract 1889: Smad4 inactivation correlates with EMT and cetuximab resistance in head and neck squamous cell carcinoma
2012 · Haixia Cheng, Elana Fertig, et al. · Cancer Research · 3
Abstract LB-247: Early detection of gastric cancer using global and gene-specific promoter DNA methylation in endoscopic biopsies
2017 · Francesca Pirini, Sassan Noazin, et al. · Cancer Research · 1
Argininosuccinate synthetase 1 (ASS1) expression and response to arginine deprivation with ADI-PEG20 in human papillomavirus (HPV)-positive head and neck squamous cell carcinoma (HNSCC).
2014 · Jason Howard, Jimena Perez, et al. · Journal of Clinical Oncology · 1
Abstract 3100: MicroRNA profiling reveals miR-205 upregulation is associated with head and neck squamous cell carcinoma and modulates E2F1 signaling.
2013 · Jason D. Howard, Haixia Cheng, et al. · Cancer Research · 1
Suppl Fig Table Legends from SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells
2023 · Hiroyuki Ozawa, Ruchira S. Ranaweera, et al.
Supplemental Figure 2 from SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells
2023 · Hiroyuki Ozawa, Ruchira S. Ranaweera, et al.
PDF
Supplemental Figure 5 from SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells
2023 · Hiroyuki Ozawa, Ruchira S. Ranaweera, et al.
PDF
Supplemental Figure 4 from SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells
2023 · Hiroyuki Ozawa, Ruchira S. Ranaweera, et al.
PDF
Suppl Fig Table Legends from SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells
2023 · Hiroyuki Ozawa, Ruchira S. Ranaweera, et al.
Figure S1 from SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells
2023 · Hiroyuki Ozawa, Ruchira S. Ranaweera, et al.
Supplemental Figure 2 from SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells
2023 · Hiroyuki Ozawa, Ruchira S. Ranaweera, et al.
Supplemental Figure 4 from SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells
2023 · Hiroyuki Ozawa, Ruchira S. Ranaweera, et al.
Supplemental Figure 5 from SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells
2023 · Hiroyuki Ozawa, Ruchira S. Ranaweera, et al.
Works count: 39
Citation count: 352
H-index: 9
I10-index: 9
Year
Topic
Type